News

BioSpace3d
As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’
AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...
BioSpace5d
AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills
Friday’s deal with CSPC fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in ...